RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$973M
AUM Growth
+$326M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1
+$90.2M
2
+$56M
3
+$52.9M
4
RPRX
Repros Therapeutics Inc.
RPRX
+$27.8M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$20M

Top Sells

1
+$23.3M
2
+$11.6M
3
+$8.48M
4
ENZ
Enzo Biochem, Inc.
ENZ
+$6.62M
5
NVAX icon
Novavax
NVAX
+$4.88M

Sector Composition

1 Healthcare 84.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$94.4M 9.7%
5,222,053
-5,219
2
$76.9M 7.9%
23,366,007
3
$68.6M 7.05%
+2,428,571
4
$66.8M 6.86%
7,436,470
+5,816,773
5
$62.1M 6.38%
196,769
-36,433
6
$62M 6.37%
1,737,856
+137,401
7
$61.6M 6.33%
+1,541,078
8
$59.6M 6.12%
1,554,918
-86,249
9
$48.3M 4.96%
2,941,916
+892,696
10
$46M 4.72%
4,347,456
11
$45M 4.62%
496,913
-43,681
12
$32.3M 3.32%
1,788,395
13
$32.2M 3.31%
23,187
14
$32M 3.28%
2,725,000
15
$25.7M 2.64%
981,761
+229,323
16
$25.5M 2.62%
+1,439,048
17
$20.6M 2.12%
700,000
18
$18.8M 1.93%
+1,169,084
19
$17M 1.74%
1,339,039
-655,837
20
$12.5M 1.29%
656,767
21
$10.6M 1.09%
36,085
22
$10.5M 1.08%
255,566
+136,805
23
$10.1M 1.03%
+300,801
24
$7.4M 0.76%
+450,000
25
$6.08M 0.62%
250,000
-919,898
1
2